Chemotherapy in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of carbendazim in treating patients who
have advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborators:
Cancer Therapy and Research Center, Texas National Cancer Institute (NCI)